AAAAAA
Results:
1-15
|
Results: 15
Authors:
Williamson, DJ
Hargreaves, RJ
Citation: Dj. Williamson et Rj. Hargreaves, Neurogenic inflammation in the context of migraine, MICROSC RES, 53(3), 2001, pp. 167-178
Authors:
Harrison, T
Owens, AP
Williams, BJ
Swain, CJ
Williams, A
Carlson, EJ
Rycroft, W
Tattersall, FD
Cascieri, MA
Chicchi, GG
Sadowski, S
Rupniak, NMJ
Hargreaves, RJ
Citation: T. Harrison et al., An orally active, water-soluble neurokinin-1 receptor antagonist suitable for both intravenous and oral clinical administration, J MED CHEM, 44(24), 2001, pp. 4296-4299
Authors:
Williamson, DJ
Hill, RG
Shepheard, SL
Hargreaves, RJ
Citation: Dj. Williamson et al., The anti-migraine 5-HT1B/1D agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs, BR J PHARM, 133(7), 2001, pp. 1029-1034
Authors:
Williamson, DJ
Shepheard, SL
Cook, DA
Hargreaves, RJ
Hill, RG
Cumberbatch, MJ
Citation: Dj. Williamson et al., Role of opioid receptors in neurogenic dural vasodilation and sensitization of trigeminal neurones in anaesthetized rats, BR J PHARM, 133(6), 2001, pp. 807-814
Authors:
Silberstein, SD
Hargreaves, RJ
Citation: Sd. Silberstein et Rj. Hargreaves, The history and pharmacology of ergotamine and dihydroergotamine, MG CLIN NEU, 17, 2000, pp. 52-65
Authors:
Hargreaves, RJ
Longmore, J
Beer, M
Shepheard, S
Cumberbatch, M
Williamson, D
Stanton, J
Razzaque, Z
Sohal, B
Street, L
Seabrook, G
Hill, R
Citation: Rj. Hargreaves et al., The pharmacology and mechanisms of action of rizatriptan, MG CLIN NEU, 17, 2000, pp. 141-161
Authors:
Hargreaves, RJ
Citation: Rj. Hargreaves, Pharmacology and potential mechanisms of action of rizatriptan, CEPHALALGIA, 20, 2000, pp. 2-9
Authors:
Ma, QP
Hargreaves, RJ
Citation: Qp. Ma et Rj. Hargreaves, Localization of N-methyl-D-aspartate NR2B subunits on primary sensory neurons that give rise to small-caliber sciatic nerve fibers in rats, NEUROSCIENC, 101(3), 2000, pp. 699-707
Authors:
Tattersall, FD
Rycroft, W
Cumberbatch, M
Mason, G
Tye, S
Williamson, DJ
Hale, JJ
Mills, SG
Finke, PE
MacCoss, M
Sadowski, S
Ber, E
Cascieri, M
Hill, RG
MacIntyre, DE
Hargreaves, RJ
Citation: Fd. Tattersall et al., The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L758,298, inhibit acute and delayed cisplatin-inducedemesis in ferrets, NEUROPHARM, 39(4), 2000, pp. 652-663
Authors:
Goadsby, PJ
Hargreaves, RJ
Citation: Pj. Goadsby et Rj. Hargreaves, Mechanisms of action of serotonin 5-HT1B/1D agonists: Insights into migraine pathophysiology using rizatriptan, NEUROLOGY, 55(9), 2000, pp. S8-S14
Authors:
Hargreaves, RJ
Shepheard, SL
Citation: Rj. Hargreaves et Sl. Shepheard, Pathophysiology of migraine - New insights, CAN J NEUR, 26, 1999, pp. S12-S19
Authors:
Cumberbatch, MJ
Williamson, DJ
Mason, GS
Hill, RG
Hargreaves, RJ
Citation: Mj. Cumberbatch et al., Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT1B/1D agonist, BR J PHARM, 126(6), 1999, pp. 1478-1486
Authors:
Dahlof, CGH
Hargreaves, RJ
Citation: Cgh. Dahlof et Rj. Hargreaves, Pathophysiology and pharmacology of migraine. Is there a place for antiemetics in future treatment strategies?, CEPHALALGIA, 18(9), 1998, pp. 593-604
Authors:
Cumberbatch, MJ
Hill, RG
Hargreaves, RJ
Citation: Mj. Cumberbatch et al., Differential effects of the 5HT(1B/1D) receptor agonist naratriptan on trigeminal versus spinal nociceptive responses, CEPHALALGIA, 18(10), 1998, pp. 659-663
Authors:
Cumberbatch, MJ
Hill, RG
Hargreaves, RJ
Citation: Mj. Cumberbatch et al., The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats, EUR J PHARM, 362(1), 1998, pp. 43-46
Risultati:
1-15
|